Rat weight and weight of the heart chambers.

<p>There were no significant differences between the rats. BW: body weight, HW: heart weight, LV: left ventricle, RV: right ventricle, RA: right atrium, LA: left atrium. IVS: interventriclular septum. Mean± SD.</p

Primer and probe sequences.

<p>Primer and probe sequences.</p

ANP gene expression in the cardiac chambers.

<p>Sample sizes were 10 rats in each group. Error bars indicate SEM. RV: right ventricle, RA: right atrium, LV: left ventricle, LA: left atrium. TBP: TATA-box binding protein. *P<0.05; **p<0.01; ***p<0.001 compared to the control group.</p

Plasma hormone levels of BNP, pro-ANP, ET-1 and TNI.

<p>Plasma hormone levels of BNP, pro-ANP, ET-1 and TNI.</p

BNP gene expression in the cardiac chambers.

<p>Sample sizes were 10 rats in each group. Error bars indicate SEM. RV: right ventricle, RA: right atrium, LV: left ventricle, LA: left atrium. TBP: TATA-box binding protein. *P<0.05; **p<0.01; ***p<0.001 compared to the control group.</p

Optimal filter setting, primer- and probe-concentration for the genes investigated.

<p>Optimal filter setting, primer- and probe-concentration for the genes investigated.</p

The plasma level of sICAM-1 expressed as mean ±SEM of <i>n</i> = 8–12.

<p>**p<0.01 HIV-1Tg vs. control rats.</p

Gene expression relative to the calibrator (RQC) expressed as mean ±SEM of <i>n</i> = 8–12.

<p>(A) LOX-1: *<i>p</i><0.05 aortic arch, HIV-1Tg vs. control rats; ^Δ<i>p</i><0.05 control rats, aortic arch vs. abdominal aorta. (B) VCAM-1: *<i>p</i><0.05 aortic arch, HIV-1Tg vs. control rats; ^Δ<i>p</i><0.05 HIV-1Tg rats, aortic arch vs. abdominal aorta. (C) ICAM-1: ^ΔΔΔ<i>p</i><0.001 control rats, aortic arch vs. abdominal aorta.</p

Comparison of HIV patients with and without perfusion defects.

<p>*) two-sample t-test or Fisher's exact test. MPS, myocardial perfusion scintigraphy.BP, blood pressure.hsCRP, high-sensitivity C-reactive protein. sVCAM-1, soluble vascular cell adhesion molecule-1. sICAM-1, intercellular adhesion molecule-1. MMP9, matrix metallopeptidase 9.tPAI-1, tissue-type plasminogen activator inhibitor-1.</p><p>&) adjusted for metabolic syndrome, smoking status, age, gender, cholesterol, triglycerides, glucose and systolic blood pressure.</p

Characteristics of the study groups.

<p>*) Paired t-test or Related sample McNemar's test when categorical variables. NRTI, nucleoside reverse transcriptase inhibitor.NNRTI, non-nucleoside reverse transcriptaseinhibitor. PI, proteaseinhibitor. II, integraseinhibitor. EI, entry inhibitor.CHD, coronary heart disease.</p